1,25-Dihydroxyvitamin D3 increases the growth-promoting activity of autocrine epidermal growth factor receptor ligands in keratinocytes

Endocrinology

Volumn 140, Issue 2, 1999, Pages 713-721

  Garach Jehoshua, Osnat ^a   Ravid, Amiram ^a   Liberman, Uri A ^a   Koren, Ruth ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CHLORATE; EPIDERMAL GROWTH FACTOR RECEPTOR; HEXADIMETHRINE BROMIDE;

ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; DRUG EFFECT; DRUG RECEPTOR BINDING; GROWTH REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; LIGAND BINDING; MITOGENICITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0032954170     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.2.6520     Document Type: Article

References (45)

1. 1. Bikle DD, Pillai S 1993 Vitamin D, calcium and epidermal differentiation. Endocr Rev 14:3-19
2. 2. Itin PH, Pittelkow MR, Kumar R 1994 Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium. Endocrinology 135:1793-1798
3. 3 on primary mouse epidermal keratinocyte proliferation. J Cell Physiol 163:248-256
4. 4. Gniadecki R 1996 Stimulation versus inhibition of keratinocyte growth by 1,25-dihydroxyvitamin D3: dependence on cell culture conditions. J Invest Dermatol 106:510-516
5. 3 analogues in a cell density-, calcium-and serum-dependent manner. Pharmacol Toxicol 80:49-56
6. 3 induces epidermal hyperplasia in normal mouse skin. J Invest Dermatol 100:s592
7. 7. Levy J, Gassmuller J, Schroder G, Audring H, Sonnichsen N 1994 Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness. Skin Pharmacol 7:231-236
8. 8. Lutzow-Holm C, De Angelis P, Clausen OPF 1996 Calcitriol and its analog KH 1060 induce similar changes in keratinocyte cell cycle progression after topical application to mouse skin. A bromodeoxyuridine pulse-chase flow cytometric study. J Invest Dermatol Symp Proc 1:54-59
9. 3. Biochem Pharmacol 49:621-624
10. 10. Tian XQ, Chen TC, Holick MF 1995 1,25-dihydroxyvitamin D3: a novel agent for enhancing wound healing. J Cell Biochem 59:53-56
11. 11. Gniadecki R 1994 A vitamin D analogue KH 1060 activates the protein kinase C-c-fos signalling pathway to stimulate epidermal proliferation in murine skin. J Endocrinol 143:521-525
12. 12. Stoll S, Garner W, Elder J 1997 Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation in skin organ culture. J Clin Invest 100:1271-1281
13. 13. Woodworth CD, McMullin E, Iglesias M, Plowman GD 1995 Interleukin 1α and tumor necrosis factor α stimulate autocrine amphiregulin expression and proliferation of human papilloma virus-immortalized and carcinoma-derived cervical epithelial cells. Proc Natl Acad Sci USA 92:2840-2844
14. 14. Hashimoto K, Higashiyama S, Asada H, Hashimura E, Kobayashi T, Sudo K, Nakagawa T, Damm D, Yoshikawa K, Taniguchi N 1994 Heparin-binding EGF-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem 269:20060-20066
15. 15. Piepkorn M, Lo C, Plowman GD 1994 Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. J Cell Physiol 159:114-120
16. 16. Beerli RR, Hynes NE 1996 Epidermal growth factor related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J Biol Chem 271:6071-6076
17. 17. Marikovsky M, Lavi S, Pinkas-Kramarsky R, Karunagaran D, Liu N, Wen D, Yarden Y 1995 ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Oncogene 10:1403-1411
18. 18. Alroy I, Yarden Y 1997 The ErbB signaling network in embryogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 410:83-86
19. 19. Graus-Porta D, Beerli RR, Daly JM, Hynes NE 1997 ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16:1647-1655
20. 20. Boukamp P, Petrusevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE 1988 Normal keratinization in a spontaneously immortalized aneuploid keratinocyte cell line. J Cell Biol 106:761-771
21. 21. Klapper LN, Vaisman N, Hurwitz E, Pinkas-Kramarsky R, Yarden Y, Sela M 1997 A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors. Oncogene 14:2099-2109
22. 3 and agents that increase intracellular cAMP synergistically inhibit fibroblast proliferation. In Vitro Cell Dev Biol Anim 33:310-314
23. 23. Svennevig K, Prudz K, Kolset SO 1995 Proteoglycans in polarized epithelial Madin-Darby canine kidney cells. Biochem J 311:881-888
24. 24. Minamide LS, Bamburg JR 1990 A filter paper dye-binding assay for quantitative determination of protein without interference from reducing agents or detergents. Anal Biochem 190:66-70
25. 25. Peus D, Hamacher L, Pittelkow MR 1997 EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation. J Invest Dermatol 109:751-756
26. 26. Osherov N, Levitzki A 1994 Epidermal growth factor dependent activation of the src-family kinases. Eur J Biochem 225:1047-1053
27. 27. Sunada H, Magun BE, Mendelsohn J, Macleod CL 1986 Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation. Proc Natl Acad Sci USA 83:3825-3829
28. 28. Bosenberg MW, Massague J 1993 Juxtacrine cell signaling molecules. Curr Opin Cell Biol 5:832-838
29. 29. Higashiyama S, Iwamoto R, Goishi K, Raab G, Taniguchi N, Klagsbrun M, Mekada E 1995 The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin binding EGF-like growth factor. J Cell Biol 128:929-938
30. 30. Cook PW, Ashton NM, Karkaria CE, Siess DC, Shipley GD 1995 Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity. J Cell Physiol 163:418-429
31. 31. Aviezer D, Yayon A 1994 Heparin dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. Proc Natl Acad Sci USA 91:12173-12177
32. 32. Besner GE, Whelton D, Crissman-Combs MA, Steffen CL, Kim GY, Brigstock DR 1992 Interaction of heparin-binding EGF-like growth factor with pidermal growth factor receptor: modulation by heparin, heparinase, or synthetic heparin binding HB-EGF fragments. Growth Factors 7:289-296
33. 33. Ahmed NU, Ueda M, Ichihashi M 1997 Increased level of c-erbB-2/neu/ HER-2 protein in cutaneous squamous cell carcinoma. Br J Dermatol 136:908-912
34. 34. Wright M, Grim J, Deshane J, Kim M, Strong TV, Siegal GP, Curiel DT 1997 An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2. Gene Ther 4:317-322
35. 35. Emkey R, Kahn CR 1997 Cross-talk between phorbol-mediated signaling and tyrosíne kinase proto-oncogenes. I. Activation of protein kinase C stimulates tyrosíne phosphorylation and activation of ErbB2 and ErbB3. J Biol Chem 272:31172-31181
36. 36. Tortora G, Damiano V, Bianco C, Baldassarre G, Bianco AR, Lanfrancone L, Pelicci PG, Ciardiello F 1997 The Rialpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene 14:923-928
37. 37. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM 1996 Role of CBP/P300 in nuclear receptor signalling. Nature 383:99-103
38. 3 on induction of chondrocyte maturation in culture: extracellular matrix gene expression and morphology. Endocrinology 126:1599-1609
39. 39. Ito Y, Li JS, Takahashi T, Imanishi Y, Okabayashi Y, Kido Y, Kasuga M 1997 Enhancement of the mitogenic effect by artifical juxtacrine stimulation using immobilized EGF. J Biochem (Tokyo) 121:514-520
40. 3 on normal human keratinocytes cultured in serum-free medium. Biochem Biophys Res Commun 166:916-923
41. 3 increases epidermal growth factor receptor gene expression in BT-20 breast carcinoma cells. Biochem Biophys Res Commun 176:1-6
42. 3 and rat vascular smooth muscle cell growth. Hypertension 13:954-959
43. 3 in normal human keratinocytes. J Invest Dermatol 106:1212-1217
44. MAPK pathway. J Biol Chem 271:20608-20616
45. 45. Marikovsky M, Breuing K, Liu PY, Eriksson E, Higashiyama S, Farber P, Abraham J, Klagsbrun M 1993 Appearance of a heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci USA 90:3889-3893